Growth Metrics

Axogen (AXGN) EPS (Weighted Average and Diluted) (2019 - 2025)

Axogen (AXGN) has 8 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.28 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 2390.6% year-over-year to -$0.28; the TTM value through Dec 2025 reached -$0.34, down 47.83%, while the annual FY2025 figure was -$0.34, 47.83% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.28 in Q4 2025 per AXGN's latest filing, down from $0.01 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.01 in Q4 2024 and bottomed at -$0.28 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.12, with a median of -$0.12 recorded in 2021.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 125.0% in 2025, down 2390.6% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.12 in 2021, then decreased by 8.33% to -$0.13 in 2022, then skyrocketed by 30.77% to -$0.09 in 2023, then surged by 113.58% to $0.01 in 2024, then crashed by 2390.6% to -$0.28 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.28 in Q4 2025, $0.01 in Q3 2025, and $0.01 in Q2 2025.